derazantinib
Derazantinib is a drug used to treat Intrahepatic Cholangiocarcinoma, Combined Hepatocellular and Cholangiocarcinoma, and Gastric Adenocarcinoma. Derazantinib is being actively studied in 3 studies; no studies for this drug have been completed so far.
| Top Sponsors | Top Sites | Top Investigators |
|---|---|---|
| Basilea Pharmaceutica | Beatson West of Scotland Cancer Centre | |
| Institut fur Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | Fondazione IRCCS Istituto Nazionale dei Tumori | |
| Samsung Medical Center |
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
